CLINICAL_TRIALS
trial_result
· 2024-11-29
Clinical Trial Update: NEPHSTROM for Diabetic Kidney Disease [Phase 1, Phase 2]
Summary
Phase 1/2 clinical trial NEPHSTROM for diabetic kidney disease has been terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Mario Negri Institute for Pharmacological Research | Conditions: Diabetic Kidney Disease | Phase 1, Phase 2 | Status: TERMINATED